IPO Boutique

Hancock Jaffe Laboratories, Inc. IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Hancock Jaffe Laboratories, Inc., and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Hancock Jaffe Laboratories, Inc.HJLI -
NASDAQ
$6.00-$8.00 $5.00 $5.001.5 million5/31/2018
Network 1 Financial
Co-Manager(s):
Health Care
Filing(s):

Filed 2017-09-07
Terms Added 2017-11-06
Underwriters Added 2017-12-05
Amended Prospectus 2017-12-14
Updated Prospectus 2018-05-14
Updated Prospectus 2018-05-22



Hancock Jaffe Laboratories, Inc. Quote & Chart - Click for current quote - HJLI

About Hancock Jaffe Laboratories, Inc. (adapted from Hancock Jaffe Laboratories, Inc. prospectus):
They are a development stage medical device company developing biologic based solutions that are designed to be life-enhancing for patients with cardiovascular disease, peripheral arterial and venous disease, and end stage renal disease, or ESRD.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "HJLI" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved